Influenza surveillance is conducted as a part of the National Epidemiological Surveillance of Infectious Diseases (NESID) by the Ministry of Health, Labor, and Welfare, Japan.
Skyrocketing price tags for new drugs to treat rare diseases have stoked outrage nationwide. But hundreds of old, commonly used drugs cost the Medicaid program billions of extra dollars in 2016 vs. 2015, a Kaiser Health News data analysis shows. Eighty of the drugs — some generic and some still carrying brand names — proved more than two decades old.